Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-07-23FDA Approved: ZYPREXA INTRAMUSCULAR — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Zyprexa Intramuscular (olanzapine) from Eli Lilly, adding the intramuscular formulation to the p…
-
FDA approval · 2015-07-23FDA Approved: ZYPREXA RELPREVV — Supplemental Application (H2-Pharma LLC)
The FDA approved a supplemental application for ZYPREXA RELPREVV (olanzapine pamoate) submitted by H2-Pharma LLC, related to the long-acting…
-
FDA approval · 2015-07-10FDA Approved: REXULTI — Original Application (Otsuka America Pharmaceutical, Inc.)
FDA approved Rexulti (brexpiprazole) from Otsuka America Pharmaceutical as the original approval for the treatment of schizophrenia in adult…
-
FDA approval · 2015-06-16FDA Approved: INVEGA SUSTENNA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for INVEGA SUSTENNA (paliperidone palmitate) from Janssen Pharmaceuticals, Inc. The action relates t…
-
FDA approval · 2015-06-09FDA Approved: INVEGA SUSTENNA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for INVEGA SUSTENNA (paliperidone palmitate) from Janssen Pharmaceuticals, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-05-18FDA Approved: INVEGA HAFYERA — Original Application (Janssen Pharmaceuticals, Inc)
FDA approved INVEGA HAFYERA (paliperidone palmitate) from Janssen Pharmaceuticals in an Original Application. It is a long-acting injectable…
-
FDA approval · 2015-04-28FDA Approved: ARIPIPRAZOLE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic's original ANDA for aripiprazole, a generic version of the antipsychotic.
-
FDA approval · 2015-04-28FDA Approved: ARIPIPRAZOLE — Original Application (Exelan Pharmaceuticals, Inc.)
FDA approved a generic aripiprazole tablet under ANDA205064 for Exelan Pharmaceuticals, authorizing sale for the same indications as the bra…
-
FDA approval · 2015-04-23FDA Approved: RISPERIDONE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for risperidone from Aurobindo Pharma Limited under an ANDA.
-
FDA approval · 2015-04-13FDA Approved: ZIPRASIDONE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for ziprasidone submitted by Dr. Reddy's Laboratories Limited.
-
FDA approval · 2015-03-30FDA Approved: FANAPT — Supplemental Application (Vanda Pharmaceuticals Inc.)
FDA approved a supplemental application for FANAPT (iloperidone) submitted by Vanda Pharmaceuticals Inc.
-
FDA approval · 2015-03-20FDA Approved: MOLINDONE HYDROCHLORIDE — Original Application (EPIC PHARMA, LLC)
FDA approved molindone hydrochloride as a generic drug through an Original Application by EPIC PHARMA, LLC.
-
FDA approval · 2015-03-18FDA Approved: ZIPRASIDONE HYDROCHLORIDE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for ziprasidone hydrochloride by Apotex Corp., approving the generic product under the ANDA.
-
FDA approval · 2015-03-17FDA Approved: RISPERIDONE — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved a supplemental application for risperidone by Ajanta Pharma USA Inc., expanding its regulatory clearance for additional indicat…
-
FDA approval · 2015-02-20FDA Approved: OLANZAPINE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Macleods Pharmaceuticals Limited's generic olanzapine (oral) under ANDA203044. It covers indications for schizophrenia and bipo…
-
FDA approval · 2015-02-04FDA Approved: ZIPRASIDONE — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for Ziprasidone from Chartwell RX, LLC, enabling a generic version of the antipsychotic to be ma…
-
FDA approval · 2015-01-20FDA Approved: OLANZAPINE — Supplemental Application (Dr. Reddy's Laboratories Inc.)
FDA approved a supplemental application for the generic olanzapine, manufactured by Dr. Reddy's Laboratories Inc.
-
FDA approval · 2015-01-17FDA Approved: OLANZAPINE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved Torrent Pharmaceuticals Limited's supplemental application for olanzapine (generic) under the ANDA pathway. This represents a s…
-
FDA approval · 2015-01-12FDA Approved: RISPERIDONE — Original Application (Chartwell RX, LLC)
FDA approved Chartwell RX, LLC's generic risperidone through an original ANDA submission, marking the first approval of this generic product…
-
FDA approval · 2015-01-05FDA Approved: LATUDA — Supplemental Application (Sumitomo Pharma America, Inc.)
The FDA approved a supplemental application for LATUDA (lurasidone hydrochloride) submitted by Sumitomo Pharma America, Inc.
-
FDA approval · 2015-01-05FDA Approved: ABILIFY MAINTENA — Supplemental Application (Otsuka America Pharmaceutical, Inc.)
FDA approves a supplemental application for ABILIFY MAINTENA (aripiprazole) submitted by Otsuka America Pharmaceutical, Inc.
-
FDA approval · 2014-12-20FDA Approved: OLANZAPINE — Supplemental Application (Dr. Reddy's Laboratories Ltd.)
FDA approved Dr. Reddy's Laboratories Ltd.'s supplemental application for olanzapine, enabling a generic olanzapine product.
-
FDA approval · 2014-12-19FDA Approved: CLOZARIL — Supplemental Application (HLS Therapeutics (USA), Inc.)
FDA approved a supplemental application for Clozaril (clozapine) submitted by HLS Therapeutics (USA), Inc.
-
FDA approval · 2014-12-19FDA Approved: ZYPREXA RELPREVV — Supplemental Application (H2-Pharma LLC)
FDA approved a supplemental application for ZYPREXA RELPREVV (olanzapine pamoate) submitted by H2-Pharma LLC.
-
FDA approval · 2014-12-13FDA Approved: PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for a generic Perphenazine and Amitriptyline Hydrochloride product manufactured by Mylan Pharmac…